Company / SG&A Expense
IMMUCELL CORP /DE/ SG&A Expense History
FY2011-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$2.2M
FY2025
5-year range
$1.3M / $2.3M
FY2021-FY2025
Trend
+3.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
SG&A Expense has fluctuated over the past 10 years, ranging from $849,064 in FY2012 to $2M in FY2023.
Based on SEC 10-K filings.
$2M in FY2025 with a 10-year CAGR of +9.0%.
Improved from $2M to $2M over the past 2 years.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- +9.0%
Key checks
Key Insights
- In FY2025, sg&a expense increased 3.9% year-over-year.
- Peak sg&a expense was recorded in FY2023.
- Lowest sg&a expense in the period was in FY2012.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.2M | +3.9% |
| FY2024 | $2.1M | -5.7% |
| FY2023 | $2.3M | +55.6% |
| FY2017 | $1.5M | +13.1% |
| FY2016 | $1.3M | +37.0% |
| FY2015 | $939.2K | +2.3% |
| FY2014 | $918.4K | +7.2% |
| FY2013 | $856.6K | +0.9% |
| FY2012 | $849.1K | -2.7% |
| FY2011 | $872.5K | - |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026